CaliPharms, Inc. (KGET)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 15, 2026
CaliPharms Market Cap
CaliPharms has a market cap or net worth of $13.88 thousand as of January 21, 2026.
Market Cap
13.88K
Enterprise Value
n/a
Revenue
112.47K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 24, 2013, CaliPharms's market cap has decreased from 36.51K to 13.88K, a decrease of -61.99%. That is a compound annual growth rate of -7.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 13.88K | - |
| Dec 31, 2025 | 13.88K | - |
| Dec 31, 2024 | 13.88K | - |
| Dec 29, 2023 | 13.88K | - |
| Dec 29, 2022 | 13.88K | - |
| Dec 31, 2021 | 13.88K | -98.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EVIO, Inc. | 19.19K |
| Amazonas Florestal, | 17.62K |
| Nutranomics | 16.75K |
| Veritas Farms | 16.30K |
| Anbc, Inc. | 15.92K |
| Medcann Industries | 15.90K |
| AREV Life Sciences Global | 15.88K |
| Aeolus Pharmaceuticals | 15.21K |